近期，深圳細(xì)胞谷全資子公司廣東君厚生物醫(yī)藥有限公司榮獲2022年中山市第九批創(chuàng)新科研團(tuán)隊(duì)項(xiàng)目立項(xiàng)并獲得數(shù)百萬(wàn)元政府支持資金。

Recently, Guangdong Junhou Biomedicine Co., LTD., a wholly-owned subsidiary of Shenzhen Cell Valley, won the ninth batch of innovative scientific research team project in Zhongshan in 2022 and obtained millions of yuan of government support funds.

On the morning of December 7, Junhou Biology successfully held the launch meeting of the innovative scientific research team project. Shenzhen Cell Valley and Junhou Biology Chairman Shi Yuanyuan, chief scientist Wang Jianxun, Junhou Biology Executive President Yang Bolui, Vice president Feng Yaru, Chief Executive Officer Sun Rui, Shenzhen Cell Valley Chairman assistant Wei Zheng, General office director Luan Zhishi attended the project kick-off meeting; At the same time, we specially invited Professor Huang Xi of Guangdong Province "Pearl River Scholar", chief scientist of the National Major infectious diseases Special project, academic director of the Fifth Affiliated Hospital of Sun Yat-sen University, Deputy director of Zhongshan Institute of Clinical Medicine, Director Wang Weijia of the Laboratory Medicine Center of the Municipal People's Hospital, and Dr. Chen Zhenxing, general manager of Qinyuan Regenerative Medicine and other cell therapy experts to guide the official launch of the project.

First of all, Professor Shi Yuanyuan, the project leader and chairman of Shenzhen Cell Valley and Junhou Biology, introduced the background and main contents of the project. Then, the heads of each department reported the plan and arrangement of this project, including production & R&D plan, industrialization process of results, administrative management system, fund review system, etc. The experts and leaders at the meeting fully affirmed the project plan and arrangement of each department, and provided a lot of valuable opinions on the follow-up project work. At the same time, the development of new forms of anti-virus vectors in the cell therapy industry was discussed. Professor Huang Xi said that he is very willing to try the new track of retroviral vector, and is willing to cooperate with Junhou Biology to develop new products in the future.

Finally, Chairman Shi Yuanyuan made a summary of the project launching ceremony and had high hopes for the development of the project. The holding of this launch meeting not only further clarified the node requirements of the project implementation progress, but also proposed detailed planning for the follow-up work of the project. The official launch of the innovative scientific research team project of Shenzhen Cell Valley Company Junhou Biology means that Shenzhen Cell Valley further steps towards a new development milestone, better play the advantages of retroviral vectors, continue to provide customers with the best service, and embark on a new journey.